Application of N-aminophthalimide in analysis of unsaturated lipid and unsaturated lipid analysis method

By reacting N-aminophthalimide with carbon-carbon double bonds to form N-heterocyclopropane, combined with liquid chromatography-mass spectrometry, the double bond position and cis-reverse in unsaturated lipids in the prior art were solved. The problem of isomer analysis achieves efficient and accurate lipidome analysis.

CN118961914APending Publication Date: 2024-11-15INST OF CHEM CHINESE ACAD OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410931401.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-12
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The prior art is difficult to effectively analyze the carbon-carbon double bond position and cis-trans isomerization in unsaturated lipids, especially the separation efficiency and accuracy of macromolecules, which limits the in-depth analysis of the lipid group.

Method used

N-aminophthalimide is used as the carbon-carbon double bond derivatization reagent in lipids, and reacts with carbon-carbon double bonds to form N-heterocyclopropane. Unsaturated lipids are detected and analyzed by liquid chromatography-mass spectrometry combination. double bond positions and trans isomerism in the

Benefits of technology

Accurate analysis of the carbon-carbon double bond position and cis-trans isomer in unsaturated lipids is achieved, which improves separation efficiency and accuracy, reduces the retention time of cis-trans isomer on the column, and increases the resolution.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118961914A_ABST
    Figure CN118961914A_ABST
Patent Text Reader

Abstract

The invention provides an application of N-aminophthalimide in analysis of unsaturated lipid and an unsaturated lipid analysis method, and the application of N-aminophthalimide in analysis of unsaturated lipid is characterized in that when the unsaturated lipid is analyzed by using a liquid chromatography-mass spectrometry method, the content of N-aminophthalimide in the unsaturated lipid is reduced, and the content of N-aminophthalimide in the unsaturated lipid is reduced. N-aminophthalimide is used as a carbon-carbon double bond derivatization reagent in the lipid. According to the present invention, the N-aminophthalimide can react with the carbon-carbon double bond to form the N-heterocyclic propane, such that the N-aminophthalimide can be adopted as the carbon-carbon double bond derivatization reagent in the lipid so as to be used for analyzing the unsaturated lipid;
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of mass spectrometry detection, and in particular to an application of N-aminophthalimide in analyzing unsaturated lipids and an unsaturated lipid analysis method. Background Art

[0002] Lipids are a class of biological molecules that play a vital role in organisms. They are widely present in various cells, tissues and organs, providing an important material basis for the composition of life. They can participate in signal transduction, energy storage or replenishment, and coordinated metabolism. Their biological functions depend largely on their chemical structure. Unsaturated lipids are a subclass of lipids, containing single or multiple C=C bonds in the fatty acyl chain. The position and configuration of the C=C bond are two basic properties of lipid structure. Its isomer types include positional isomers and geometric isomers (cis-trans or ZE configuration), which give lipids different structures and functions in organisms. The fine structural information of these lipids has also been found to be related to diseases. For example, the content ratio of Δ9 and Δ11 double bond position isomers of lipids PC 16:0_18:1, PC 18:0_18:1, and PC20:3_18:1 containing C18:1 fatty acyl chains in the plasma of patients with type 2 diabetes was significantly lower than that of normal control plasma (P<0.001); for another example, the content of LPC 18:1(n-9) increased in bladder cancer tissue, while the content of its double bond position isomer LPC 18:1(n-7) decreased. Therefore, it is very necessary to conduct in-depth analysis of the fine structure of lipids (double bond position and cis-trans isomers, etc.), which can provide richer lipid structure and function information.

[0003] Many outstanding scholars have done excellent work on the position information of double bonds in unsaturated fatty acid chains in lipid structures. For example, when a carbonyl-containing compound such as m-trifluoroacetophenone reacts with double bonds under ultraviolet light, the resulting O-heterocyclobutane can be fragmented in the mass spectrometry ion source to produce double bond position fragments. There are also double bonds that are oxidized to N-heterocyclopropane using transition metals or α,β-unsaturated carbonyl compounds as catalysts to achieve the positioning of double bonds and relative quantitative analysis of unsaturated lipids. Regarding the configuration information of double bonds in unsaturated fatty acid chains in lipid structures (cis-trans isomerism of double bonds), there are relatively few studies at present, and the results are not good. For example, when ultra-high performance liquid chromatography (UHPLC) is used to separate cis-trans isomerized lipids, although lipids with smaller molecular weight and simpler structure (such as FA) can be separated on a reverse chromatographic column, lipids with larger molecular weight (GPL, CE, etc.) cannot achieve baseline separation. For another example, Takashi Baba et al. used electron impact excitation of organic ions (EIEIO) mass spectrometry to fragment unsaturated lipids. The relative intensity of the fragments produced by the fragmentation of carbon-carbon single bonds adjacent to double bonds was different, and this was used to determine cis-trans isomers. The above methods of using instruments to separate cis-trans isomers have high instrument requirements, and the limitations of instrument conditions are not conducive to large-scale lipid group analysis.

[0004] To this end, the present invention is proposed. Summary of the invention

[0005] The main purpose of the present invention is to propose an application of N-aminophthalimide in the analysis of unsaturated lipids and an unsaturated lipid analysis method. The N-aminophthalimide in the present invention can react with a carbon-carbon double bond to form an N-heterocyclopropane, thereby realizing the use of N-aminophthalimide as a carbon-carbon double bond derivatization reagent in lipids for the analysis of unsaturated lipids.

[0006] In order to achieve the above objectives, the present invention provides the following technical solutions.

[0007] The first aspect of the present invention provides an application of N-aminophthalimide in analyzing unsaturated lipids. When analyzing unsaturated lipids by liquid chromatography-mass spectrometry, N-aminophthalimide is used as a derivatization agent for carbon-carbon double bonds in lipids.

[0008] The present invention proposes a new use of N-aminophthalimide (PhthNH2) as a carbon-carbon double bond derivatization reagent in lipids to react with carbon-carbon double bonds to form N-heterocyclopropane, which is applied to the analysis of unsaturated lipids.

[0009] In some embodiments of the present invention, the analysis of unsaturated lipids includes determining the position and / or cis-trans isomerism of carbon-carbon double bonds in the lipids.

[0010] In some embodiments of the present invention, the novel use of PhthNH2 described in the present invention is to simultaneously detect the carbon-carbon double bond position and cis-trans isomerism of lipids.

[0011] In some embodiments of the present invention, the unsaturated lipids include at least one of fatty acids, cholesterol esters, glycerides, and glycerophospholipids.

[0012] A second aspect of the present invention provides an unsaturated lipid analysis method, the analysis method comprising the following steps:

[0013] Using N-aminophthalimide as a derivatization reagent for a lipid standard solution or a lipid extract of a biological sample, a derivatization reaction is performed to obtain an N-heterocyclopropane derivatized product;

[0014] Liquid chromatography-mass spectrometry is used to detect and analyze the N-heterocyclopropane derivatized product to determine the position and / or cis-trans isomerism of the carbon-carbon double bond in the lipid.

[0015] In some embodiments of the present invention, the position of the carbon-carbon double bond of the lipid is determined based on the secondary fragment spectrum, and the one with a later retention time in the chromatogram is the cis configuration (Z configuration), and the one with an earlier retention time is the trans configuration (E configuration).

[0016] In some embodiments of the present invention, the biological sample in the biological sample lipid extract is at least one of plasma, serum, cerebrospinal fluid, cell extract, organ and tissue.

[0017] In some embodiments of the present invention, the lipid standard solution is an alcohol solution containing lipid standards.

[0018] In some embodiments of the present invention, the lipid standards include FA 16:1(9Z), FA 16:1(9E), FA18:1(6Z), FA 18:1(6E), FA 18:1(9Z), FA 18:1(9E), FA 18:1(11Z), FA 18:1(11E), FA20:1(11Z), FA20:1(11E), FA 22:1(13Z), FA 22:1(13E), FA 18:2(9Z,11E), FA 18:2(9Z,12Z), FA 18:3(9Z,12Z,15Z), FA 20:4(5Z,8Z,11Z,14Z), LPA 18:1(9Z), PA 16:0 / 18:1(9Z), PS16:0 / 18:1(9Z), PC At least one of 16:0 / 18:1(9Z), PC 16:0 / 18:1(9E), PC 18:1(9Z) / 18:1(9Z), PC 18:1(9E) / 18:1(9E), PE 18:1(9Z) / 18:1(9Z), DG 16:0 / 18:1(9Z), TG 18:1(9Z) / 18:1(9Z) / 18:1(9Z), TG 18:2(9Z,12Z) / 18:2(9Z,12Z) / 18:2(9Z,12Z), CE 18:1(9Z), CE 18:1(9E), CE18:2(9Z,12Z).

[0019] In some embodiments of the present invention, the temperature of the derivatization reaction is 0°C to 50°C, and the reaction time is 5 min to 30 min. The experimental results of the reaction temperature and reaction time conditions are as follows: Figure 1 shown.

[0020] The temperature of the derivatization reaction provided by the present invention can be a value in the interval consisting of any two values ​​in the above range, for example, it can be 0°C to 20°C, or 30°C to 50°C, and so on. The temperature of the derivatization reaction provided by the present invention can also be one of 0°C, 5°C, 8°C, 10°C, 15°C, 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, or any value that meets the above range.

[0021] The reaction time of the derivatization reaction provided by the present invention can be a value in the interval consisting of any two values ​​in the above range, for example, it can be 5min to 10min, or 10min to 30min, and so on. The reaction time of the derivatization reaction provided by the present invention can also be one of 5min, 10min, 15min, 20min, 25min, 30min, or any value that satisfies the above range.

[0022] In some embodiments of the present invention, an oxidant and a base are further added to the lipid standard solution or the biological sample lipid extract to perform a derivatization reaction.

[0023] In some embodiments of the invention, the oxidant comprises iodobenzene diacetate and the base comprises potassium carbonate.

[0024] In some embodiments of the present invention, when the amount of the unsaturated lipid substance is 1 mol, the amount of N-aminophthalimide required to be added for the derivatization reaction is 1.4 to 2.4 mol, calculated on a molar basis of the number of double bonds, for example, it may be one of 1.4 mol, 1.5 mol, 1.6 mol, 1.7 mol, 1.8 mol, 1.9 mol, 2.0 mol, 2.1 mol, 2.2 mol, 2.3 mol, 2.4 mol or any value satisfying the above range.

[0025] In some embodiments of the present invention, based on the molar amount of double bonds, when the amount of the unsaturated lipid substance is 1 mol, the amount of iodobenzene diacetate and potassium carbonate required to be added for the derivatization reaction is 1.6-2.6 mol and 1.9-2.9 mol respectively.

[0026] The amount of iodobenzene diacetate required for the derivatization reaction of the present invention may be one of 1.6 mol, 1.7 mol, 1.8 mol, 1.9 mol, 2.0 mol, 2.1 mol, 2.2 mol, 2.3 mol, 2.4 mol, 2.5 mol, 2.6 mol or any value satisfying the above range.

[0027] The amount of potassium carbonate added to the derivatization reaction of the present invention may be one of 1.9 mol, 2.0 mol, 2.1 mol, 2.2 mol, 2.3 mol, 2.4 mol, 2.5 mol, 2.6 mol, 2.7 mol, 2.8 mol, 2.9 mol or any value satisfying the above range.

[0028] In some embodiments of the present invention, the preparation of the biological sample lipid extract comprises:

[0029] A homogenate prepared from a solid biological sample or a liquid biological sample is added with methanol for lipid extraction;

[0030] The upper organic phase after lipid extraction was added with methyl tert-butyl ether and water for secondary extraction;

[0031] The upper organic phase after the secondary extraction is dried with nitrogen gas, and methanol is added to redissolve it to obtain the biological sample lipid extract.

[0032] In some embodiments of the present invention, the unsaturated lipid analysis method provided by the present invention comprises the following steps:

[0033] 1) Extraction of lipids:

[0034] The lipid standard is prepared into a 1 mmol lipid standard solution using methanol. And

[0035] The extraction steps of the biological sample lipids are as follows: the solid biological sample is made into a 200 mg / mL homogenate using ultrapure water, 100uL of the homogenate (or 20uL of the liquid biological sample) is taken, 160uL of methanol is added, the mixture is shaken for 30s, and ultrasonicated in ice water for 10min. Then 800uL of methyl tert-butyl ether (MTBE) and 300uL of water are added, the mixture is shaken for 30s, and ultrasonicated in ice water for 10min. Centrifuge at 10000g for 10min at 4℃, collect the upper organic phase, repeat the above operation to extract the lower aqueous phase once, integrate the extracted organic phase, blow dry with nitrogen, and re-dissolve in 100uL of methanol for the next derivatization operation.

[0036] 2) Derivatization of lipids: Take 100uL of 1mmol lipid standard solution or 100uL of lipid extract of biological sample in step 1), add PhthNH2 (DCM solution), diacetoxyiodobenzene (PhI(AcO)2) (DCM solution) and potassium carbonate and mix well. When the amount of unsaturated lipid substance (in terms of molar amount of double bonds) is 1 equivalent, the amount of PhthNH2 required for the derivatization reaction is 1.4-2.4 equivalents, PhI(AcO)2 is 1.6-2.6 equivalents, and potassium carbonate is 1.9-2.9 equivalents. The mixture was reacted at 0°C to 50°C for 5min to 30min, and then 400uL of chloroform and 500uL of water were added thereto. The lower organic phase was collected after centrifugation and dried with nitrogen gas. The mixture was redissolved with 100uL of methanol (or 1mL of a mixed solution of acetonitrile aqueous solution (volume ratio ACN:H2O=7:3) with 10mmol of ammonium formate (NH4FA) and 0.1% formic acid (FA)).

[0037] 3) After the treatment in step 1) and step 2), the cis-trans isomerism and position of the carbon-carbon double bond are analyzed by UHPLC-ESI-HR-MS / MS, and the double bond position of the lipid is determined by characteristic fragments. The cis configuration (Z configuration) is at a later retention time in the chromatogram, and the trans configuration (E configuration) is at an earlier retention time.

[0038] Compared with the prior art, the present invention achieves the following technical effects:

[0039] The present invention proposes a new use of N-aminophthalimide (PhthNH2) as a carbon-carbon double bond derivatization reagent in lipids to react with carbon-carbon double bonds to form N-heterocyclopropane, which is applied to the analysis of unsaturated lipids.

[0040] The application of PhthNH2 provided by the present invention includes two points: first, confirmation of the double bond position: the structure of N-heterocyclopropane formed after the reaction of PhthNH2 with the carbon-carbon double bond will be fragmented in the mass spectrum to form secondary fragment ions specific to the double bond position, thereby performing a qualitative analysis of the double bond position of the lipid; second, analysis of double bond cis-trans isomerism: the cis-trans isomerism of the lipid double bond is still retained after derivatization, the polarity difference between the cis-trans isomers is increased and the overall polarity of the molecule is improved, reducing the retention time of cis-trans isomers on the reverse chromatographic column while increasing the separation efficiency, and through the derivatization experiments of a large number of lipid standards, the chromatographic retention characteristics of cis-trans isomers are summarized, that is, the cis configuration (Z configuration) is retained later, and the trans configuration (E configuration) is retained earlier.

[0041] The above description is only an overview of the technical solution of the present invention. In order to more clearly understand the technical means of the present invention, it can be implemented according to the contents of the specification. In order to make the above and other purposes, features and advantages of the present invention more obvious and easy to understand, the specific implementation methods of the present invention are listed below. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] Various other advantages and benefits will become apparent to those of ordinary skill in the art by reading the detailed description of the preferred embodiments below. The accompanying drawings are only used for the purpose of illustrating the preferred embodiments and are not to be considered as limiting the present invention. In the accompanying drawings:

[0043] Figure 1 The method is to screen the conditions for the derivatization reaction; wherein (a) is the signal intensity of the derivatization product at different reaction times; (b) is the signal intensity of the derivatization product at different reaction temperatures;

[0044] Figure 2 are chromatograms before and after derivatization of monounsaturated lipids; wherein, (a) and (b) are chromatograms of FA 18:1(9Z) and FA18:1(9E) before and after derivatization; (c) and (d) are chromatograms of CE 18:1(9Z) and CE 18:1(9E) before and after derivatization; (e) and (f) are chromatograms of PC 16:0 / 18:1(9Z) and PC 16:0 / 18:1(9E) before and after derivatization;

[0045] Figure 3The chromatograms are before and after derivatization of monounsaturated fatty acids with different chain lengths and double bond positions; (a) and (b) are chromatograms of FA 16:1(9Z) and FA 16:1(9E) before and after derivatization; (c) and (d) are chromatograms of FA18:1(6Z) and FA18:1(6E) before and after derivatization; (e) and (f) are chromatograms of FA18:1(11Z) and FA18:1(11E) before and after derivatization; (g) and (h) are chromatograms of FA20:1(11Z) and FA20:1(11E) before and after derivatization; (i) and (j) are chromatograms of FA 22:1(13Z) and FA22:1(13E) before and after derivatization;

[0046] Figure 4 The chromatograms are before and after derivatization of polyunsaturated lipids containing two double bonds; (a) and (b) are the chromatograms of FA18:2(9Z,12Z) before and after derivatization; (c) and (d) are the chromatograms of CE 18:2(9Z,12Z) before and after derivatization; (e) and (f) are the chromatograms of PC 18:1(9Z) / 18:1(9Z) and PC 18:1(9E) / 18:1(9E) before and after derivatization;

[0047] Figure 5 (a) shows the fragmentation mechanism of secondary fragments produced after FA18:1(9Z) derivatization;

[0048] Figure 5(b) is the primary spectrum after FA18:1(9Z) derivatization;

[0049] Figure 5(c) is the secondary spectrum after FA 18:1(9Z) derivatization (MS2 of 443.29);

[0050] Figure 5(d) is the secondary mass spectrum after FA18:2(9Z,12Z) derivatization;

[0051] Figure 5(e) is the secondary mass spectrum after FA 18:3 (9Z, 12Z, 15Z) derivatization;

[0052] Figure 5(f) is the secondary mass spectrum after derivatization of FA 20:4 (5Z, 8Z, 11Z, 14Z);

[0053] Figure 5(g) is the secondary mass spectrum after CE 18:1(9Z) derivatization;

[0054] Figure 5(h) is the secondary mass spectrum after PE 18:1(9Z) / 18:1(9Z) derivatization;

[0055] Figure 5(i) is the secondary mass spectrum after TG 18:1(9Z) / 18:1(9Z) / 18:1(9Z) derivatization;

[0056] The following are lipids detected after derivatization in mouse kidney tissue homogenate; among them,

[0057] Figure 6 (a) is the extracted ion chromatogram of m / z 948.6436 and the secondary spectrum of the chromatographic peak at RT = 6.01 min;

[0058] Figure 6(b) is the extracted ion chromatogram of m / z 878.5329 and the secondary spectrum of the chromatographic peak at RT = 5.76 min;

[0059] Figure 6(c) is the extracted ion chromatogram of m / z 876.5496 and the secondary spectrum of the chromatographic peak at RT = 5.50 min;

[0060] Figure 6(d) is the extracted ion chromatogram of m / z 1017.7844 and the secondary spectra of the chromatographic peaks at RT = 9.41 min, RT = 9.56 min, and RT = 9.74 min. DETAILED DESCRIPTION

[0061] Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings. However, it should be understood that these descriptions are exemplary only and are not intended to limit the scope of the present invention. In addition, in the following description, descriptions of known structures and technologies are omitted to avoid unnecessary confusion of the concept of the present invention.

[0062] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by technicians in the technical field to which the present invention belongs; the terms used herein are only for the purpose of describing specific embodiments and are not intended to limit the present invention; the terms "including" and "having" in the specification and claims of the present invention and the above-mentioned figure descriptions and any variations thereof are intended to cover non-exclusive inclusions.

[0063] Reference to "embodiments" herein means that a particular feature, structure, or characteristic described in conjunction with the embodiments may be included in at least one embodiment of the present invention. The appearance of the phrase in various places in the specification does not necessarily refer to the same embodiment, nor is it an independent or alternative embodiment that is mutually exclusive with other embodiments. It is explicitly and implicitly understood by those skilled in the art that the embodiments described herein may be combined with other embodiments.

[0064] In the description of the embodiments of the present invention, the term "and / or" is only a description of the association relationship of associated objects, indicating that three relationships may exist. For example, A and / or B may represent: A exists alone, A and B exist at the same time, and B exists alone. In addition, the character " / " in this article generally indicates that the associated objects before and after are in an "or" relationship.

[0065] If no specific technology or conditions are specified in the following examples, the technology or conditions described in the literature in this field or the product instructions are used. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased through regular channels. The experimental methods in the following examples are all conventional methods unless otherwise specified. The test materials used in the following examples are all commercially available products unless otherwise specified.

[0066] Example 1

[0067] The instrument used in Example 1 is liquid chromatography (I-class Acquity ultra performance liquid chromatography, Waters) tandem mass spectrometry (QTRAP 4500, AB SCIEX INSTRUMENTS).

[0068] The liquid chromatography parameters are as follows: the chromatographic column used is ACQUITYTM PRIMIER UPLC BEH C18 (2.1x100mm, 1.7μm); column temperature: 50°C; sample plate temperature: 4°C; mobile phase, gradient and flow rate are shown in Table 1.

[0069] The mass spectrometry parameters were as follows: MRM mode; curtain gas: 10; electrospray voltage: positive ion +4500 V, negative ion -4500 V; collision gas: medium; ion source temperature: 300°C; ion source gas 1: 30; ion source gas 2: 30. Analyst 1.6.3 (SCIEX) software was used for data acquisition and processing.

[0070] A polyunsaturated lipid standard containing two double bonds is prepared into a 1mmol / L lipid standard solution using methanol, or a 1mmol / L cis-trans isomer lipid standard mixed solution is prepared using cis- and trans-isomer lipid standard solutions in a 1:1 ratio. Before the derivatization reaction, the above lipid standard solution or the cis-trans isomer lipid standard mixed solution is first taken for liquid chromatography-tandem mass spectrometry (LC-MS / MS) analysis; then 100uL of the above lipid standard solution or 100uL of the cis-trans isomer lipid standard mixed solution is taken into an EP tube, and 100uL of 1.4mmol / L isomer lipid standard is added. PhthNH2 dichloromethane (DCM) solution, 20uL 8mmol / L diacetyl iodobenzene (PhI(AcO)2) dichloromethane solution and 2.7mg potassium carbonate were mixed and reacted at room temperature 25°C for 10min, and then 400uL chloroform and 500uL water were added thereto, mixed and centrifuged, and the lower organic phase was collected and dried with nitrogen gas, and re-dissolved with 1mL acetonitrile aqueous solution (volume ratio of acetonitrile: H2O is 7:3) and a mixed solution of 10mmol / L ammonium formate (NH4FA) and 0.1% formic acid (FA) to obtain a derivatized lipid standard solution or a derivatized cis-trans isomer lipid standard mixed solution. Take 100uL of the derivatized lipid standard solution or 100uL of the derivatized cis-trans isomer lipid standard mixed solution for liquid chromatography-tandem mass spectrometry (LC-MS / MS) analysis.

[0071] Among them, the lipid standards used in Example 1 include FA 18:1(9Z), FA18:1(9E), CE 18:1(9Z), CE 18:1(9E), PC 16:0 / 18:1(9Z), PC 16:0 / 18:1(9E), FA16:1(9Z), FA16:1(9E), FA18:1(6Z), FA18:1(6E), FA 18:1(11Z), FA18:1(11E), FA 20:1(11Z), FA 20:1(11E), FA 22:1(13Z), FA 22:1(13E), FA 18:2(9Z,12Z), CE 18:2(9Z,12Z), PC 18:1(9Z) / 18:1(9Z), PC18:1(9E) / 18:1(9E).

[0072] The experimental results are as follows Figure 2 , Figure 3 and Figure 4 As shown, Figure 2 The chromatograms before and after derivatization of monounsaturated lipids are shown in Figure 2. Figure 3 The chromatograms of monounsaturated fatty acids with different chain lengths and double bond positions before and after derivatization are shown. Figure 4 Chromatograms of polyunsaturated lipids containing two double bonds before and after derivatization.

[0073] Combination Figure 2 and Figure 3 It can be seen that before derivatization, the cis configuration (Z) is at the front and the trans configuration (E) is at the back; after derivatization, the trans configuration (E) is at the front and the cis configuration (Z) is at the back, and the overall retention time moves forward, and the Z / E configuration separation increases. Therefore, the cis and trans isomers of lipids can be confirmed by looking at the relative positions of the chromatographic peaks without the need for standard samples.

[0074] Depend on Figure 4 It can be seen that FA18:2(9Z,12Z), CE 18:2(9Z,12Z) and PC 18:1(9Z) / 18:1(9Z) can all distinguish cis and trans isomers after derivatization. The analytical method of the present invention can distinguish cis and trans isomers of lipids containing two double bonds.

[0075] Example 2

[0076] The instrument used in Example 2 is liquid chromatography (UltiMate 3000 system, Thermo Fisher Scientific) and tandem mass spectrometry (Orbitrap Fusion Lumos, Thermo Fisher Scientific).

[0077] The liquid chromatography parameters are as follows: the chromatographic column used is ACQUITYTM PRIMIER UPLC BEH C18 (2.1x100mm, 1.7μm); column temperature: 50°C; sample plate temperature: 4°C; mobile phase, gradient and flow rate are shown in Table 1.

[0078] The mass spectrometry parameters are as follows: electrospray voltage: +3500 V; sheath gas: 50; auxiliary gas: 15; sweep gas: 2; ion transfer tube temperature = 320 °C; vaporizer temperature = 300 °C; MS1 scan range: m / z = 150-1500; detector type: orbitrap; orbitrap resolution: 120 K; filter precursor selection range: m / z = 400-1500; MS2 isolation mode: quadrupole; isolation window: 2; activation type: HCD; collision energy (%) = 30; stepped collision energy (%) = 7; detector type: orbitrap; orbitrap resolution: 120 K; filter precursor selection range: m / z = 400-1500; MS2 isolation mode: quadrupole; isolation window: 2; activation type: HCD; collision energy (%) = 30; stepped collision energy (%) = 7; detection type: orbitrap; orbitrap resolution: 120 K Xcalibur (version 4.4) software was used for data acquisition and processing.

[0079] The lipid standard was prepared into a 1 mmol / L lipid standard solution using methanol, 100 uL was taken into an EP tube, 100 uL of 1.4 mmol / L PhthNH2 in dichloromethane solution, 20 uL of 8 mmol / L PhI(AcO)2 in dichloromethane solution and 2.7 mg of potassium carbonate were added and mixed, and the mixture was reacted at room temperature of 25°C for 10 min. Then 400 uL of chloroform and 500 uL of water were added thereto, the lower organic phase was collected after mixing and centrifugation, dried with nitrogen, and re-dissolved with 1 mL of acetonitrile aqueous solution (volume ratio ACN:H2O=7:3) and a mixed solution of 10 mmol / L NH4FA and 0.1% FA, and analyzed by liquid chromatography-tandem mass spectrometry (LC-MS / MS).

[0080] Among them, the lipid standards used in Example 2 include FA 18:1(9Z), FA 18:2(9Z,12Z), FA 18:3(9Z,12Z,15Z), CE 18:1(9Z), PE 18:1(9Z) / 18:1(9Z), TG 18:1(9Z) / 18:1(9Z) / 18:1(9Z), and FA 20:4(5Z,8Z,11Z,14Z).

[0081] The experimental results are as follows Figure 5(a) to Figure 5(i) As shown, Figure 5(a) shows the fragmentation mechanism of secondary fragments after FA 18:1(9Z) derivatization, and Figures 5(b) and 5(c) show the primary and secondary spectra (MS2 of 443.29) after FA 18:1(9Z) derivatization. Figure 5(d) to Figure 5(i) This is the secondary mass spectrum after derivatization of other types of unsaturated lipids. The corresponding double bond position-specific fragments are marked in the figure. The naming method of the double bond position-specific fragments is as follows: the fragment containing the methyl end is annotated as Fa, the fragment containing the functional group (carboxyl, ester, etc.) end is annotated as Fb, and the fragment in which Fb loses a part of water is annotated as Fbd. The fragments generated by the double bond at (ΔX) are named F(CX)a or F(CX)b, and "C" is the number of carbons on the fatty acyl chain.

[0082] The results showed that the carbon-carbon double bond, after derivatization to form the N-heterocyclopropane structure, would be more fragile in the mass spectrometry collision cell, thus forming double-bond-specific fragments of the imine type, indicating the location of the double bond.

[0083] Example 3

[0084] The instrument used in Example 3 is liquid chromatography (UltiMate 3000 system, Thermo Fisher Scientific) and tandem mass spectrometry (Orbitrap Fusion Lumos, Thermo Fisher Scientific).

[0085] The liquid chromatography parameters are as follows: the chromatographic column used is ACQUITYTM PRIMIER UPLC BEH C18 (2.1x100mm, 1.7μm); column temperature: 50°C; sample plate temperature: 4°C; mobile phase, gradient and flow rate are shown in Table 1.

[0086] The mass spectrometry parameters are as follows: electrospray voltage: +3500 V; sheath gas: 50; auxiliary gas: 15; sweep gas: 2; ion transfer tube temperature = 320 °C; vaporizer temperature = 300 °C; MS1 scan range: m / z = 150-1500; detector type: orbitrap; orbitrap resolution: 120 K; filter precursor selection range: m / z = 400-1500; MS2 isolation mode: quadrupole; isolation window: 2; activation type: HCD; collision energy (%) = 30; stepped collision energy (%) = 7; detector type: orbitrap; orbitrap resolution: 120 K; filter precursor selection range: m / z = 400-1500; MS2 isolation mode: quadrupole; isolation window: 2; activation type: HCD; collision energy (%) = 30; stepped collision energy (%) = 7; detection type: orbitrap; orbitrap resolution: 120 K Xcalibur (version 4.4) software was used for data acquisition and processing.

[0087] The kidney tissues of C57BL / 6 mice were immediately removed after CO2 asphyxiation euthanasia and stored at -80°C. The freeze-dried tissues were weighed and added to ultrapure water (weight / volume = 200 mg / mL). After homogenization, 100uL of the homogenate was taken, 160uL of methanol was added, mixed and shaken for 30s, and ultrasonicated in ice water for 10min. Then 800uL of methyl tert-butyl ether (MTBE) and 300uL of water were added, mixed and shaken for 30s, and ultrasonicated in ice water for 10min. The mixture was centrifuged at 10000 g for 10 min at 4 °C, and the upper organic phase was collected. The lower aqueous phase was extracted again by repeating the above operation. The organic phases extracted twice were integrated, dried with nitrogen, and redissolved with 100 uL of methanol. 100 uL of 1.4 mmol / L PhhthNH2 in dichloromethane, 20 uL of 8 mmol / L PhI(AcO)2 in dichloromethane and 2.7 mg of potassium carbonate were added and mixed. The mixture was reacted at room temperature at 25 °C for 10 min, and 400 uL of chloroform and 500 uL of water were added. The lower organic phase was collected after mixing and centrifugation, dried with nitrogen, and redissolved with 100 uL of methanol for liquid chromatography-tandem mass spectrometry (LC-MS / MS) analysis.

[0088] The detailed structural analysis of lipids in mouse kidney tissue homogenate is as follows.

[0089] Taking the m / z 948.6436 fragment ion as an example, the extracted ion chromatogram and MS / MS spectrum are shown in Figure 6(a).

[0090] The strongest peak in the MS / MS spectrum is m / z=184.0735, which indicates that the molecule is a PC lipid. Combining library retrieval (lipid maps) and fragment ions, the composition of its fatty acyl chain is FA 18:0 (m / z664.3735) (M-FA 18:0) and FA 18:1 (m / z 425.2799) (FA+PhthNH2). The extracted ion chromatogram indicates that the retention times of its Z / E configuration are 6.01min and 5.90min respectively; the F9a fragment ion with an m / z of 287.1756 in the low molecular weight section (m / z 180-330) of the MS / MS spectrum indicates that the double bond is at the n-9 position. Therefore, the molecule is PC 18:0_18:1 (Δ9) (E: 5.90min, Z: 6.01min), and the Z / E configuration content ratio is 5.73.

[0091] Similarly, the analysis process of the ion with m / z 878.5329 is similar (see Figure 6(b)). The secondary spectrum of the ion with m / z 878.5329 has a signal of phosphorylation of ethanolamine (-141Da) (m / z 737.5426), which indicates that the molecule is a PE lipid. m / z 425.2797 and m / z 397.2848 correspond to the characteristic fragments of carboxyl terminal dehydration after derivatization of FA 18:1 and FA 16:1, respectively. Therefore, the chain composition of the molecule PE 34:1 can be determined to be PE 16:0_18:1 and PE 16:1_18:0. The XIC spectrum can determine the difference in retention time of its Z / E configuration (E: 5.66min, Z: 5.76min), and the content ratio is 8.56. In the Z configuration, the content ratio of PE 16:0_18:1 to PE 16:1_18:0 is 15.56. In the low molecular weight region, double bonds located at n-2, n-3, n-4, n-6, n-7, n-8, n-9, n-10, and n-11 can be observed. Based on the structural composition of FA lipids and lipid synthesis pathways such as Kennedy Pathway, it is inferred that FA 16:1 contains two positional isomers, (Δ7) and (Δ9). In the Z configuration, their relative contents are 84.83% and 15.17%, respectively; FA 18:1 contains double bond position isomers of (Δ7)(Δ8)(Δ9)(Δ10)(Δ11)(Δ12)(Δ14)(Δ15)(Δ16). In the Z configuration, their relative contents are 0.49%, 1.36%, 46.27%, 0.70%, 8.27%, 7.76%, 0.57%, 2.33% and 32.25%, respectively.

[0092] As for lipids containing two double bonds, the secondary fragment of m / z 876.5496 contains a characteristic fragment (m / z 735.5309) of phosphorylethanolamine (-141Da) (see Figure 6(c)), so this molecule belongs to the PE lipid class. Its secondary spectrum can be determined to have a fatty acyl chain composition of 16:0 (m / z 313.2737) (FA16:0+Gly)_18:2) (m / z=423.2643). The XIC spectrum can be used to determine the difference in retention time of its ZZ / ZE configuration) (ZE: 5.39min, ZZ: 5.50min), and the content ratio is 32.11. In the ZZ configuration, the secondary fragments in the low molecular weight region (m / z 180-330) showed that the molecule was PE 16:0_18:2 (Δ9, Δ11) and PE 16:0_18:2 (Δ9, Δ12). The relative quantification of isomers at different positions can also be performed based on the intensity of the fragments at the double bond position. The peak intensity of F6a (m / z 245.1285) was 1.26*10 5 , F7a (m / z 259.1441) peak intensity is 5.24*104 Therefore, the relative content of these two configurations is IPE 16:0_18:2(Δ9,Δ12) / IPE 16:0_18:2(Δ9,Δ11)=2.4.

[0093] As for polyunsaturated lipids such as TG 52:3 (see Figure 6(d)), through analysis of three chromatographic peaks and the corresponding secondary spectra (m / z 380-450), its composition is: TG 16:0_18:0_18:3 (RT=9.41min), TG 16:1_18:1_18:1 (RT=9.56min), TG 16:1_18:0_18:2 (RT=9.74min). Taking TG 16:1_18:0_18:2 (RT=9.74min) as an example, due to the large number of double bond positions and the lack of standard samples, cis- and trans-isomers are difficult to infer. However, the low molecular weight segment (m / z 180-330) in its secondary spectrum can determine that FA 16:1 contains two positional isomers, (Δ7) and (Δ9), and FA 18:2 includes two positional isomers, (Δ9, Δ11) and (Δ9, Δ12).

[0094] Table 1 Summary of mobile phases, gradients and flow rates for LC-MS in Examples 1-3

[0095]

[0096] The application of PhthNH2 provided in the embodiment of the present invention includes two points: first, confirmation of the double bond position: the structure of N-heterocyclopropane formed after PhthNH2 reacts with the carbon-carbon double bond will be fragmented in the mass spectrum to form a double bond position-specific secondary fragment ion, thereby performing a qualitative analysis of the double bond position of the lipid; second, analysis of double bond cis-trans isomerism: after derivatization, the overall polarity of the lipid molecule is increased, reducing the retention time on the reverse chromatographic column, while the cis-trans isomerism of the lipid double bond is still retained, and the separation degree is increased on the reverse chromatographic column, which can be used for double bond cis-trans isomerism analysis. And through the derivatization experiments of a large number of lipid standards, the chromatographic retention characteristics of cis-trans isomers are summarized, that is, the cis configuration (Z configuration) is retained later, and the trans configuration (E configuration) is retained earlier.

[0097] After the present invention used this method to derivatize lipids extracted from biological samples, the results showed that PhthNH2 could also derivatize lipids extracted from biological samples. Subsequently, UHPLC-ESI-HR-MS / MS was combined to achieve simultaneous analysis of the carbon-carbon double bond positions and configurational isomers of unsaturated lipids in biological samples.

[0098] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit them; although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein by equivalents; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the scope of the technical solutions of the embodiments of the present invention, and they should all be included in the scope of the claims and specification of the present invention. In particular, as long as there is no structural conflict, the various technical features mentioned in each embodiment can be combined in any way. The present invention is not limited to the specific embodiments disclosed herein, but includes all technical solutions that fall within the scope of the claims.

Claims

1. Application of N-aminophthalimide in analyzing unsaturated lipids, characterized in that: When analyzing unsaturated lipids by liquid chromatography-mass spectrometry, N-aminophthalimide is used as a derivatizing agent for carbon-carbon double bonds in lipids.

2. The use according to claim 1, characterized in that The analysis of the unsaturated lipids includes determining the position and / or cis-trans isomerism of the carbon-carbon double bonds in the lipids.

3. The use according to claim 1, characterized in that The unsaturated lipids include at least one of fatty acids, cholesterol esters, glycerides, and glycerophospholipids.

4. A method for analyzing unsaturated lipids, characterized in that: The analytical method comprises the following steps: Using N-aminophthalimide as a derivatization reagent for a lipid standard solution or a lipid extract of a biological sample, a derivatization reaction is performed to obtain an N-heterocyclopropane derivatized product; Liquid chromatography-mass spectrometry is used to detect and analyze the N-heterocyclopropane derivatized product to determine the position and / or cis-trans isomerism of the carbon-carbon double bond in the lipid.

5. The unsaturated lipid analysis method according to claim 4, characterized in that: The biological sample in the biological sample lipid extract is at least one of plasma, serum, cerebrospinal fluid, cell extract, organ and tissue.

6. The unsaturated lipid analysis method according to claim 4, characterized in that: The lipid standard solution is an alcohol solution containing lipid standards; Preferably, the lipid standard comprises FA 16:1(9Z), FA 16:1(9E), FA 18:1(6Z), FA 18:1(6E), FA 18:1(9Z), FA 18:1(9E), FA 18:1(11Z), FA 18:1(11E), FA20:1(11Z), FA 20:1(11E), FA22:1(13Z), FA22:1(13E), FA18:2(9Z,11E), FA 18:2(9Z,12Z), FA 18:3(9Z,12Z,15Z), FA20:4(5Z,8Z,11Z,14Z), LPA 18:1(9Z), PA 16:0 / 18:1(9Z), PS16:0 / 18:1(9Z), PC At least one of 16:0 / 18:1(9Z), PC 16:0 / 18:1(9E), PC 18:1(9Z) / 18:1(9Z), PC 18:1(9E) / 18:1(9E), PE 18:1(9Z) / 18:1(9Z), DG 16:0 / 18:1(9Z), TG 18:1(9Z) / 18:1(9Z) / 18:1(9Z), TG 18:2(9Z,12Z) / 18:2(9Z,12Z) / 18:2(9Z,12Z), CE 18:1(9Z), CE 18:1(9E), CE 18:2(9Z,12Z).

7. The unsaturated lipid analysis method according to claim 4, characterized in that: The temperature of the derivatization reaction is 0°C to 50°C, and the reaction time is 5min to 30min.

8. The unsaturated lipid analysis method according to claim 4, wherein An oxidant and a base are also added to the lipid standard solution or the biological sample lipid extract to perform a derivatization reaction; Preferably, the oxidizing agent comprises iodobenzene diacetate and the base comprises potassium carbonate.

9. The unsaturated lipid analysis method according to claim 8, characterized in that: Based on the molar amount of the double bonds, when the amount of the unsaturated lipid is 1 mol, the amount of N-aminophthalimide required to be added for the derivatization reaction is 1.4 to 2.4 mol; Preferably, based on the molar amount of double bonds, when the amount of the unsaturated lipid substance is 1 mol, the amount of iodobenzene diacetate and potassium carbonate required to be added for the derivatization reaction is 1.6-2.6 mol and 1.9-2.9 mol respectively.

10. The unsaturated lipid analysis method according to claim 4, characterized in that: The preparation of the biological sample lipid extract comprises: A homogenate prepared from a solid biological sample or a liquid biological sample is added with methanol for lipid extraction; The upper organic phase after lipid extraction was added with methyl tert-butyl ether and water for secondary extraction; The upper organic phase after the secondary extraction is dried with nitrogen gas, and methanol is added to redissolve it to obtain the biological sample lipid extract.